DLBDLBIndustrials · Specialty Business Services

DLB Stock Forecast: Dolby Laboratories, Inc. Price Predictions for 2026-2027

Last close, 3 Sept 2026
$62
+0.21% on the day

The 4 Wall Street analysts covering Dolby Laboratories, Inc. hold a median 12-month price target of $85 — +37.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 78 of 100 as at 2 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$5.8B
Ticker Nerd rank
78 / 100
Median analyst target
$85
Analysts covering
4
Revenue$305.0M−3.3% y/y
Operating income$38.3M
Net income$29.2M
Free cash flow$147.7M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−0.8%
1M
+4.3%
YTD
−1.9%
1Y
−12.5%
From 52W high
−13.6%
From 52W low
+28.4%
$48
$72
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

DLB stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Dolby Laboratories, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 2 Sept 2026
78 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
95
Value
86
Accruals
80
Revisions
79
Issuance
72
Quality
71
Momentum
42
Growth
26
Size
21

Volatility (95): The share price has been relatively steady.

Growth (26): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (21): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

DLB stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on DLB, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$50$60$70$80$90Oct 25Jan 26Apr 26Jul 26DLBHigh $90Median $85Low $62

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says4 analysts
3 Buy1 Hold0 Sell
Low $62Median $85High $90

The green dot is the last close — the median target sits +37.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
28 Aug 2026RosenblattMaintainsBuy$85
31 July 2026RosenblattMaintainsBuy
31 July 2026RosenblattMaintainsBuy$85
15 June 2026Barrington ResearchMaintainsOutperform$90
15 June 2026Barrington ResearchMaintainsOutperform
11 June 2026RosenblattMaintainsBuy$85
11 June 2026RosenblattMaintainsBuy
27 Apr 2026Barrington ResearchMaintainsOutperform
30 Jan 2026Barrington ResearchMaintainsOutperform
30 Jan 2026RosenblattMaintainsBuy
26 Jan 2026Barrington ResearchMaintainsOutperform
22 Jan 2026RosenblattMaintainsBuy
19 Nov 2025Barrington ResearchMaintainsOutperform
19 Nov 2025RosenblattMaintainsBuy
12 Sept 2025Barrington ResearchMaintainsOutperform
5 Sept 2025BairdInitiatesNeutral
15 Aug 2025Tigress FinancialMaintainsBuy
1 Aug 2025RosenblattMaintainsBuy
13 June 2025RosenblattMaintainsBuy
15 May 2025Tigress FinancialMaintainsBuy

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. DLB appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

DLB vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 3 Sept 2026, Dolby Laboratories, Inc. returned −12.5% against +21.4% for the S&P 500, dividends included.

DLB vs S&P 500, last 12 monthsTotal return, rebased to 100
60708090100110120Oct 25Jan 26Apr 26Jul 26DLBS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

DLB analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.2%
Analysts raising
2
Analysts cutting
1
Fundamentals

Dolby Laboratories, Inc. (DLB) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
26.1×

Cheaper than 30% of US stocks

Price / sales
4.2×

Cheaper than 29% of US stocks

Price / book
2.2×

Cheaper than 43% of US stocks

EV / EBITDA
14.5×

Cheaper than 24% of US stocks

Growth & margins
Revenue growth (YoY)
−3.3%

Higher than 22% of US stocks

Earnings growth (YoY)
−37.9%

Higher than 13% of US stocks

Gross margin
86.8%

Higher than 95% of US stocks

Operating margin
12.5%

Higher than 68% of US stocks

Net margin
16.7%

Higher than 80% of US stocks

Returns & dividend
Return on equity
8.8%

Higher than 61% of US stocks

Return on assets
5.2%

Higher than 77% of US stocks

Dividend yield
2.3%

Higher than 52% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Dolby Laboratories, Inc. (DLB) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Dolby Laboratories, Inc. has a market value of $5.8B and an enterprise value of $5.2B.

  • Revenue in the twelve months to 30 June 2026: $1.4B. The latest quarter shrank 3.3% year on year.

  • Net income over the same four quarters: $228.0M, a 16.8% net margin.

  • Diluted earnings per share, trailing twelve months: $2.35.

  • Free cash flow in the twelve months to 30 June 2026: $344.5M.

  • Dolby Laboratories, Inc. spent $270.2M on share buybacks and $134.2M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 93.6M.

  • Trailing P/E: 26.1×; forward P/E: 13.4× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 2.34%, paying out 60% of earnings.

  • Dolby Laboratories, Inc. employs 2,051 people $660K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 1 Sept 2026

Data provided by Twelve Data

Peers

DLB vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Business Services
CompanyMarket capTKN rank
DLBDolby Laboratories, Inc.$5.8B
78
AMTMAmentum Holdings, Inc.$4.8B
71
UNFUniFirst Corp.$4.8B
78
AZZAZZ, Inc.$4.0B
83
FAFirst Advantage Corp.$3.5B
92
MMSMAXIMUS, Inc.$3.1B
78
CBZCBIZ, Inc.$3.0B
75

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Dolby Laboratories, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest DLB news & analysis

Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?

Zacks Investment Research · 1 Sept 2026positive

Zacks Investment Research has identified Dolby Laboratories (DLB) as a top-ranked growth stock, citing its strong performance relative to market benchmarks. The article highlights the Zacks Style Scores as a tool for selecting strong, market-beating stocks, positioning DLB favorably within that framework.

Why it matters — A top-ranked growth stock designation from Zacks could draw investor attention to DLB's fundamentals and growth prospects.

3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds

Zacks Investment Research · 31 Aug 2026neutral

Zacks Research highlighted DLB, along with SONY and SONO, as audio-video production industry participants that could benefit from investments in cutting-edge solutions, despite headwinds from cautious discretionary spending and macroeconomic troubles.

Why it matters — DLB watchers would note that the company is positioned among industry players that analysts see as leveraging technological investment to navigate broader sector headwinds.

Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks Investment Research · 31 Aug 2026neutral

Zacks Investment Research highlighted Dolby Laboratories (DLB) as a top-ranked momentum stock using its Style Scores feature from the Zacks Premium research service.

Why it matters — For DLB watchers, this indicates the stock is gaining attention from momentum-focused investors, which could influence trading activity.

Dolby Laboratories Announces Leadership Transition

PRNewsWire · 27 Aug 2026neutral

Dolby Laboratories announced that Kevin Yeaman is retiring after nearly two decades with the company, and Marc Whitten has been appointed President, Chief Executive Officer and a member of the Board of Directors following a long-term succession process.

Why it matters — DLB watchers would care because this marks a significant leadership transition at the top of the company.

Dividend Champion, Contender, And Challenger Highlights: Week August 16

Seeking Alpha · 14 Aug 2026neutral

A Seeking Alpha article provided a weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers, including companies that changed their dividends and upcoming ex-dividend dates.

Why it matters — DLB investors often track dividend classifications like Champions and Contenders, so any changes in Dolby's dividend status or upcoming ex-dividend dates would be relevant to income-focused shareholders.

FAQ

Frequently asked questions about DLB stock

What is the DLB stock price forecast for 2026-2027?

The 4 Wall Street analysts covering Dolby Laboratories, Inc. have a median 12-month price target of $85, with estimates ranging from $62 to $90. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is DLB stock a buy right now?

Of the 4 analysts covering Dolby Laboratories, Inc., 3 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Dolby Laboratories, Inc. 78 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank DLB?

As at 2 Sept 2026, Dolby Laboratories, Inc. ranks 78 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (95 of 100).

Will DLB stock go up?

No one can know that. What the data says: the median 12-month target from 4 analysts implies +37.3% from the last close, and Ticker Nerd's factor model ranks Dolby Laboratories, Inc. 78 out of 100 as at 2 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the DLB stock forecast for 2030?

No analyst covering Dolby Laboratories, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for DLB are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $62 to $90 over the next 12 months.

How has DLB stock performed over the past year?

Dolby Laboratories, Inc. returned -12.5% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Dolby Laboratories, Inc. do?

Dolby Laboratories Inc. Class A is a technology company that develops audio, imaging, and voice solutions used across cinema, television, streaming, gaming, mobile devices, and personal computing.

What is the latest news on DLB?

The most recent item we track (Zacks Investment Research, 1 Sept 2026): "Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?". Zacks Investment Research has identified Dolby Laboratories (DLB) as a top-ranked growth stock, citing its strong performance relative to market benchmarks. The article highlights the Zacks Style Scores as a tool for selecting strong, market-beating stocks, positioning DLB favorably within that framework.

Company

About Dolby Laboratories, Inc.

Dolby Laboratories Inc. Class A is a technology company that develops audio, imaging, and voice solutions used across cinema, television, streaming, gaming, mobile devices, and personal computing. Its current offerings center on licensing and software-enabled technologies that help content creators, device makers, broadcasters, and entertainment platforms deliver more immersive sound and picture experiences. Dolby Laboratories also provides products and services for professional cinema and media workflows, including tools for playback, encoding, and content delivery. The company’s portfolio includes well-known formats and platforms such as Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby Voice, and Dolby.io, which support consumer entertainment and enterprise communications. Headquartered in San Francisco, California, Dolby Laboratories plays a significant role in the global media technology market by supplying intellectual property and technology infrastructure that are widely embedded in modern entertainment and communications systems.

CEO Mr. Marc Whitten · 2,051 employees · United States · https://www.dolby.com